Crinetics Pharmaceuticals CRNX Sale of stock, price per share (in dollars per share)
Sale of stock, price per share (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:SaleOfStockPricePerShare.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's sale of stock, price per share (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's sale of stock, price per share (in dollars per share)?
- Crinetics Pharmaceuticals (CRNX) reported sale of stock, price per share (in dollars per share) of $45.95 in Q1 2026.